Jessica Weiser, MD
Dermatology · New York, NYNPI 1619172541
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,753 of the $83,736 with a category attached, or 79.7%. Galderma Laboratories, L.p. accounts for 76.4% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2021 at $23,355 and has fallen 58.8% since, to $9,625 in 2025. Among dermatology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 372 payments — averaging $225.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$64K
- AbbVie$12K
- Revance Therapeutics, Inc.$2K
- Johnson & Johnson$1K
- Sun Pharmaceutical Industries Inc.$529
- Viiv Healthcare Company$378
- plus $4K from 25 others
What the payments were for
- Consulting fees$1,5532%
- Speaking & faculty fees$66,75380%
- Travel & lodging$5,5527%
- Food & beverage$9,77912%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 89 | $63,938 |
| AbbVie(2 entities) | 37 | $12,010 |
| Revance Therapeutics, Inc. | 7 | $2,255 |
| Johnson & Johnson | 40 | $1,050 |
| Sun Pharmaceutical Industries Inc. | 28 | $529 |
| Viiv Healthcare Company | 14 | $378 |
| Regeneron Healthcare Solutions, Inc. | 13 | $371 |
| Amgen | 17 | $358 |
| Pfizer | 15 | $328 |
| LEO Pharma Inc. | 15 | $327 |
| Arcutis Biotherapeutics, Inc. | 17 | $307 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 17 | $284 |
| Incyte Corporation | 11 | $261 |
| Merz North America, Inc. | 2 | $194 |
| Mayne Pharma Commercial LLC | 8 | $164 |
| Lilly USA, LLC | 6 | $138 |
| Almirall LLC | 6 | $127 |
| EPI Health, LLC | 4 | $124 |
| Novartis | 4 | $113 |
| VYNE Pharmaceuticals Inc. | 5 | $106 |
| E.r. Squibb & Sons, L.L.C. | 3 | $68 |
| Botanix SB Inc | 2 | $57 |
| Journey Medical Corporation | 2 | $41 |
| Novo Nordisk | 2 | $36 |
| Dermavant Sciences, Inc. | 1 | $32 |
| Mission Pharmacal Company | 2 | $29 |
| Sanofi | 1 | $28 |
| Encore Dermatology Inc. | 1 | $25 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $23 |
| Sebela Pharmaceuticals Inc. | 1 | $19 |
| Dermira, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$83,736 in reported general payments places this provider in the 90th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 14 | $88 |
| Spironolactone | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.